LOGOLOGOLOGOLOGO
  • About us
    • What we do
    • Who we are
      • Governance
      • Staff
      • Vacancies
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Patient BioForum
      • Study – Impact of the EU’s General Pharmaceutical Legislation
    • Industrial Biotechnology Council
      • EFIB
      • Microorganisms
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
      • Biotechnology in our Lives
  • Activities
    • 25 Years of Innovation
    • The EU Biotech Act
    • European Biotech Week
    • EU Projects
      • PRIMED Project
      • APROVALS Project
  • News & Events
    • News
    • Events
  • Library
Become a member
✕

EuropaBio Annual Report 2025

14/07/2025

REPORT

The 2025 EuropaBio annual report highlights work, partnerships and accomplishments over the last year, with updates from the Healthcare, Industrial Biotechnology and National Associations Councils, plus SME and Biomanufacturing Platforms, as well as a section on EuropaBio's Communications.

In the last period, biotechnology and biomanufacturing, along with EuropaBio, have achieved unprecedented political attention across sectors, being recognised as integral to Europe’s industrial, competitive and sustainable future. The report also looks ahead for EuropaBio and biotechnology across Europe and the globe.

To find out more about Europabio membership and how you can bring your voice to the discussion, read more HERE and contact us.

EuropaBio Annual Report 2025

Download

Share
Adrian Lincoln
Adrian Lincoln

Related posts

12/11/2025

EuropaBio response to the EU Biotech Act public consultation

Read more
05/11/2025

EuropaBio recommendations for the Circular Economy Act

Read more
31/10/2025

Healthcare Associations warn of risks from PFAS restriction approach  – failure to assess the impact on the availability of human and animal medicines

Read more

Important links

  • EuropaBio response to the EU Biotech Act public consultation
  • EuropaBio recommendations for the Circular Economy Act

Categories in our Newsroom

EBIO-white
EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.
Contact us
Extra links
Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom
Become a member
Media pack
© 2025 Europabio. All Rights Reserved. Designed by EYAS
Become a member

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.